On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, ...

November is Alzheimer’s Awareness Month, a time to heighten awareness about Alzheimer’s disease and show support for the many people and families living with it.

The combination of a recently approved blood test for the detection of Alzheimer’s disease, combined with two medications that slow the progression of the disease, is drastically improving outcomes ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

New study reveals physical activity in midlife and later life can reduce dementia risk by up to 45%, offering significant hope for brain health protection.

Novo Nordisk said on Monday that two late-stage trials testing an older oral version of its semaglutide drug failed to meet their main goal.

More than nine in 10 patients treated with Roche’s next-generation Alzheimer’s disease antibody trontinemab tested negative for amyloid plaques in a mid-stage study, marking a return to the ...